Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Wastewater analysis predicts COVID-19 spread

The researchers from Yale University provided an outline of the spread of the infection in the community. Their study titled, “Measurement of SARS-CoV-2 RNA in wastewater tracks community infection dynamics,” is published in the latest issue of the journal Nature Biotechnology.

22 Sep 2020

NIH expands clinical trials to evaluate convalescent plasma as a treatment for COVID-19

Two randomized, placebo-controlled clinical trials funded by the National Institutes of Health (NIH) are expanding enrollment to further evaluate convalescent plasma as a treatment for patients hospitalized with COVID-19.

22 Sep 2020

COVID-19 can affect the retina

Now, a new study published in the journal EClinicalMedicine shows that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease (COVID-19), targets the retina.

22 Sep 2020

Respiratory specimens testing positive for SARS-CoV-2 decrease in the U.S., CDC report

In the report, published on Sept. 18, the CDC shows that indicators tracking COVID-19 activity continued to decline or remain stable. Still, two regions say a slight increase in the percentage of specimens testing positive for SARS-CoV-2. Meanwhile, four regions reported a slight increase in the percent of outpatient or emergency department visits for influenza-like illness (ILI).

22 Sep 2020

Researchers identify a potential drug candidate for hand, foot and mouth disease

A study appearing next week in the journal Nature Communications offers some good news in the search for antiviral drugs for hard-to-treat diseases. Researchers have identified a potential new drug candidate against enterovirus 71, a common cause of hand, foot and mouth disease in infants and young children

22 Sep 2020

Discovering a molecule that could interfere with SARS-CoV-2 replication

In this interview, News-Medical speaks to Stepan Nersisyan about his discovery of a molecule that could replicate SARS-CoV-2.

22 Sep 2020

Inhibition of SARS-CoV-2 with antisense oligonucleotides

A part of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral RNA is highly conserved. Researchers have used this as a target for designing antisense oligonucleotide gapmers to cleave the RNA and disrupt virus replication. Their research is published as a preprint on the online server bioRxiv in September 2020.

22 Sep 2020

Children are disproportionally harmed by precautions involved with lockdowns, say experts

Children, who appear at a relatively lower risk from COVID-19, are disproportionally harmed by precautions involved with lockdowns, say Matthew Snape and Russell Viner in a Perspective.

22 Sep 2020

BCG vaccine may offer protection against COVID-19, shows study

While scientists race to develop and test a vaccine effective against SARS-CoV-2, the virus that causes COVID-19, recent studies have indicated that countries with widespread BCG vaccination appear to be weathering the pandemic better than their counterparts.

22 Sep 2020

Cats’ immune system can deal with SARS-CoV-2, shows study

On 8 May 2020, the Institute of Agrifood Research and Technology (IRTA) reported the case of the first cat infected with SARS-CoV-2 in Spain. It was a 4-year-old cat called Negrito, who lived with a family affected by COVID-19, with one case of death.

22 Sep 2020

Social contacts increase again despite coronavirus

At the beginning of the month, 60 percent still restricted themselves in this regard. At the same time, the proportion of people concerned about the impact of the virus on their social relationships fell to 15 percent.

22 Sep 2020

COVID-19 poses a unique threat during hurricane evacuations

The 2020 hurricane season is breaking records with 23 named storms, and more are projected to develop over the next few weeks.

22 Sep 2020

Nanoparticle SARS-CoV-2 model could potentially speed the search for drugs

A team of scientists from the National Center for Advancing Translational Sciences and Naval Research Laboratory in Washington, D.C., has developed a new tool that mimics how SARS-CoV-2 -- the virus that causes COVID-19 -- infects a cell, information that could potentially speed the search for treatments against the disease.

22 Sep 2020

Belief in pandemic conspiracy theories is an obstacle to minimize the spread of COVID-19

Belief in conspiracy theories about the coronavirus pandemic is not only persistent but also is associated with reluctance to accept a COVID-19 vaccine when one becomes available and to engage in behaviors such as mask-wearing that can prevent its spread, according to researchers at the Annenberg Public Policy Center.

22 Sep 2020

Exploring how COVID-19 pandemic trajectory might unfold in the future

Researchers who adapted standard epidemiological models to explore how the COVID-19 pandemic trajectory might unfold in the next five years report diverse scenarios ranging from recurring severe epidemics to elimination.

22 Sep 2020

Impaired cytotoxic T cell response found in in elderly COVID-19 patients

Although people of any age can become infected with SARS-CoV-2, the virus that causes COVID-19, elderly patients face a higher risk of severity and death than younger patients.

22 Sep 2020

Study detects key differences in immune responses of adults and children with COVID-19

The first study comparing the immune responses of adults and children with COVID-19 has detected key differences that may contribute to understanding why children usually have milder disease than adults.

22 Sep 2020

Strength, duration of immunity will shape the future trajectory of COVID-19

New research suggests that the impact of natural and vaccine-induced immunity will be key factors in shaping the future trajectory of the global coronavirus pandemic, known as COVID-19.

21 Sep 2020

People with severe dementia are unaware of COVID-19 outbreak, indicates study

The ongoing coronavirus disease 2019 (COVID-19) pandemic has substantially affected patients with dementia and their caregivers.

21 Sep 2020

COVID-19 mitigation efforts significantly decrease influenza activity

The mitigation strategies implemented to curb the spread of COVID-19 appears to reduce the transmission of influenza in the United States, Australia, Chile, and South Africa. These strategies may augment influenza vaccines, especially for high-risk populations during the seasonal influenza transmission.

21 Sep 2020